The University of Iowa Obermann Center for Advanced Studies has recently published an article about the research of Jonathan Doorn, who is part of the Medicinal and Natural Products Chemistry (MNPC) division of the Pharmaceutical Sciences and Experimental Therapeutics (PSET) department. Doorn, who was a fall 2014 Obermann fellow-in-residence, studies Parkinson's Disease.